ARS Pharmaceuticals, Inc. - COM (SPRY)

Historical Portfolio Holders from Q4 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
63.8M
Holdings value Q3 2024
$926M
Value change Q3 2024
+$31.1M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
148
Number of buys Q3 2024
103
Number of sells Q3 2024
-34
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 63.8M $926M +$31.1M $14.50 150
2024 Q2 62.6M $532M +$21.9M $8.51 112
2024 Q1 59.9M $612M -$16.2M $10.22 114
2023 Q4 65.4M $359M -$2.74M $5.48 99
2023 Q3 66.5M $251M +$38.7M $3.78 95
2023 Q2 55.1M $369M +$11.2M $6.70 93
2023 Q1 53.4M $348M +$19.6M $6.51 88
2022 Q4 50.2M $428M +$173M $8.53 72
2022 Q3 30.4M $160M +$24.5M $5.28 59
2022 Q2 26.1M $111M -$388K $4.24 60
2022 Q1 27M $94.7M -$19.6M $3.51 67
2021 Q4 30.1M $200M -$13.2M $6.66 72
2021 Q3 28.9M $288M -$42.5M $9.98 74
2021 Q2 28M $865M +$5.24M $30.89 74
2021 Q1 27.7M $1.21B +$139M $43.63 67
2020 Q4 24.4M $1.13B +$1.12B $46.34 61